Compatibility of Different Formulations in Pentravan<sup>®</sup> and Pentravan<sup>®</sup> Plus for Transdermal Drug Delivery
The potential therapeutic benefit of transdermal delivery systems for some active pharmaceutical ingredients (APIs) has been well-established for decades within the scientific community. However, together with the clinical efficacy, there is the need for an evaluation of the stability of such APIs i...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2021-11-01
|
| Series: | Scientia Pharmaceutica |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2218-0532/89/4/51 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|